Tags: Coronavirus | regeneron | covid | coronavirus

CEO: Regeneron to Deliver 300K of COVID-19 Doses to US by January

regeneron office
(Sipa via AP Images)

By    |   Monday, 23 November 2020 02:56 PM

Regeneron has agreed to provide the United States with 300,000 doses of its newly developed COVID-19 antibody by January, according to CNBC.

On Saturday, the Food and Drug Administration gave emergency use authorization to the drug known as REGN-COV2. President Donald Trump took the drug after he contracted COVID-19 in October.

The Trump administration’s Operation Warp Speed pumped $450 million into Regeneron's development effort for the drug.

“We hope to have millions of doses available. Now still, that might not be enough,” Regeneron CEO, Dr. Leonard Schleifer, told CNBC.

“I’m hopeful that will really bring down the number of cases and that those people that still get it, because they didn’t either respond to the vaccine, or they didn’t access the vaccine or didn’t want the vaccine, that there will be this monoclonal cocktail of ours available for treatment,” he said.

© 2021 Newsmax. All rights reserved.


   
1Like our page
2Share
US
Regeneron has agreed to provide the United States with 300,000 doses of its newly developed COVID-19 antibody by January, according to CNBC. On Saturday, the Food and Drug Administration gave emergency...
regeneron, covid, coronavirus
142
2020-56-23
Monday, 23 November 2020 02:56 PM
Newsmax Media, Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved